SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17986279
Source:
http://linkedlifedata.com/resource/pubmed/id/17986279
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0027627
,
umls-concept:C0087111
,
umls-concept:C0765273
,
umls-concept:C1337013
,
umls-concept:C1550147
pubmed:issue
4
pubmed:dateCreated
2008-3-14
pubmed:abstractText
To evaluate the effects of pretreatment with the retinoid X receptor (RXR) agonist bexarotene on the efficacy of radioiodine therapy for metastases of differentiated thyroid carcinoma (DTC) with limited uptake of radioiodine (I-131).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0346653
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydronaphthalenes
,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroglobulin
,
http://linkedlifedata.com/resource/pubmed/chemical/bexarotene
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1365-2265
pubmed:author
pubmed-author:LiuYing YYY
,
pubmed-author:MorreauHans AHA
,
pubmed-author:PereiraAlberto MAM
,
pubmed-author:RomijnJohannes AJA
,
pubmed-author:SmitJohannes W AJW
,
pubmed-author:StokkelMarcel PMP
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
605-9
pubmed:meshHeading
pubmed-meshheading:17986279-Adult
,
pubmed-meshheading:17986279-Aged
,
pubmed-meshheading:17986279-Anticarcinogenic Agents
,
pubmed-meshheading:17986279-Combined Modality Therapy
,
pubmed-meshheading:17986279-Disease Progression
,
pubmed-meshheading:17986279-Female
,
pubmed-meshheading:17986279-Humans
,
pubmed-meshheading:17986279-Iodine Radioisotopes
,
pubmed-meshheading:17986279-Male
,
pubmed-meshheading:17986279-Middle Aged
,
pubmed-meshheading:17986279-Neoplasm Metastasis
,
pubmed-meshheading:17986279-Prospective Studies
,
pubmed-meshheading:17986279-Tetrahydronaphthalenes
,
pubmed-meshheading:17986279-Thyroglobulin
,
pubmed-meshheading:17986279-Thyroid Neoplasms
,
pubmed-meshheading:17986279-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
pubmed:affiliation
Department of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands.
pubmed:publicationType
Journal Article
,
Clinical Trial